Exercise Immunology Review
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.6 | Q1 | 92.0% | 1.220 | Q1 | 88.4% |
| 2024 | 3.8 | Q1 | 90.2% | 1.017 | Q1 | 84.7% |
| 2023 | 3.5 | Q1 | 89.3% | 1.431 | Q1 | 92.1% |
| 2022 | 7.3 | Q1 | 97.4% | 1.659 | Q1 | 94.2% |
| 2021 | 11.1 | Q1 | 97.4% | 1.932 | Q1 | 95.6% |
| 2020 | — | — | 1.557 | Q1 | 92.9% | |
| 2019 | — | — | 1.497 | Q1 | 92.6% | |
| 2018 | — | — | 2.638 | Q1 | 97.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
1077-5552
region
Western Europe
coverage
1996-2025